Sign up to save your podcasts
Or
Share Remdesivir for COVID-19: The NIAID Study Behind its Approval | GameChangers
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Remdesivir for COVID-19: The NIAID Study Behind its Approval | GameChangers
Recently, Remdesivir was given Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) for use in COVID based on a heretofore unpublished study. The study, conducted by NIAID, is the subject of this episode.
This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/3hn191p
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Today.it , Cecilia SonginiRecently, Remdesivir was given Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) for use in COVID based on a heretofore unpublished study. The study, conducted by NIAID, is the subject of this episode.
This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/3hn191p
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices